Parkinson's disease
AbbVie acquires mitochondria biotech to boost Parkinsonās research
Anika Sharma
AbbVie has made a significant move in the field of Parkinson’s disease by acquiring Mitokinin for an upfront payment of ...
FDA rejects Amneal’s Parkinson’s drug, $500M peak sales goal unattainable
SG Tylor
Source – Amneal Pharmaceuticals On July 3, 2023, Amneal Pharmaceuticals’ plans to launch its extended-release Parkinson’s disease treatment, IPX203, by ...
